Poolbeg Pharma PLC (POLBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0420
-0.0760 (-64.41%)
At close: May 22, 2025
Poolbeg Pharma Employees
Poolbeg Pharma had 16 employees as of December 31, 2024. The number of employees increased by 1 or 6.67% compared to the previous year.
Employees
16
Change (1Y)
1
Growth (1Y)
6.67%
Revenue / Employee
n/a
Profits / Employee
-$453,040
Market Cap
33.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16 | 1 | 6.67% |
| Dec 31, 2023 | 15 | 3 | 25.00% |
| Dec 31, 2022 | 12 | 5 | 71.43% |
| Dec 31, 2021 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| CytoDyn | 9 |
| Northwest Biotherapeutics | 25 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Poolbeg Pharma News
- 19 days ago - AIM Market Roundup: Poolbeg Pharma, Caledonian, Jaganda Mines - The Armchair Trader
- 4 months ago - FTSE 100 ends flat as US data dampens sentiment - Investomania
- 4 months ago - UK Stock Market News: Standard Chartered, Poolbeg Pharma, UK Oil & Gas - The Armchair Trader
- 5 months ago - AIM Market Roundup: Immupharma, Poolbeg, Xeros - The Armchair Trader
- 5 months ago - AIM Market round-up: Team Internet, Verici, Poolbeg Pharma - The Armchair Trader
- 5 months ago - Cathal Friels Poolbeg Pharma plunges on merger talks that would see listing move to Nasdaq - Independent Ireland
- 5 months ago - Cathal Friels Poolbeg Pharma in merger talks that could land Nasdaq listing - Independent Ireland
- 11 months ago - Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market - Accesswire